
									Total number of projects: 4
As coordinator: 0
As participant: 4
Sole participant: 0
Coordinator / Participant Ratio: 0*
| Total project funding [€]: | Projects [No]: | |||||
|---|---|---|---|---|---|---|
| Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
| 2011 | 0 | 8.841.009 | 0 | 2 | ||
| 2010 | 0 | 23.998.312 | 0 | 2 | ||
							Total number of partners: 1484
							Partner loyalty:
Frequent Partner: (> 2 projects): 585
Rare Partner: 899
Frequent / Rare Partner Ratio: 0.65
						
| Start date | Project | acronym | role | funding | partners | 
|---|---|---|---|---|---|
| 2011-02-01 | Targeting the tumour microenvironment to improve pancreatic cancer prognosis | EPC-TM-Net | participant | 3.000.000 | 17 | 
| 2011-01-01 | Predicting individual response and resistance to VEGFR/mTOR pathway therapeutic intervention using biomarkers discovered through tumour functional genomics | PREDICT | participant | 5.841.009 | 14 | 
| 2010-11-01 | ASSET: Analysing and Striking the Sensitivities of Embryonal Tumours | ASSET | participant | 11.999.156 | 19 | 
| 2010-11-01 | ASSET: Analysing and Striking the Sensitivities of Embryonal Tumours | ASSET | participant | 11.999.156 | 19 |